SEC Form 4 · accession 0001062993-18-002481
BIOSPECIFICS TECHNOLOGIES CORP · BSTC
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Michael Schamroth
Director
Period of report
Jun 4, 2018
Accepted (ET)
Jun 4, 2018 · 9:08 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000875622
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock, $0.001 par value | Jun 4, 2018 | C | 15,000 | $13.60 | A | 84,000 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F1 | $13.60 | Jun 4, 2018 | C | 15,000 | D | — | Jun 9, 2018 | Cmn Stk $.001pv | 15,000 | 0 | D |
Explanation of responses
- F1The option vests monthly with respect to 1/12 of the total number of shares until all shares underlying the option have vested.